The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

FDA accepts Regeneron's sBLA for Eylea HD in RVO with priority review; QUASAR data supports monthly dosing, target action date set for August 2025.

The juries for the 2025 Cannes Lions International Festival of Creativity were announced Thursday morning, with 10 healthcare leaders judging the Health & Wellness Lions and 10 judging the Pharma ...

The global health sector is facing challenges such as U.S.-China tariff conflicts affecting drug costs, a WHO pandemic ...

We are thrilled to welcome Chris to our team at this exciting time for Design, as we advance our portfolio of GeneTAC ® small molecules toward key clinical milestones,” said Pratik Shah, Ph.D., ...

BCC Research reveals in its new report, Alzheimer's Disease Therapeutics and Diagnostics: Global Markets, the market for ...

The EMA "concluded that the benefits of this medicine outweighed the risks, in a particular population of patients with such ...

Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 5.89%, which has investors questioning if this is right time to ...

Shares of Biogen Inc. BIIB shed 1.44% to $115.29 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug ...